SE9101807D0 - Framstaellning och anvaendning av porfyriner - Google Patents

Framstaellning och anvaendning av porfyriner

Info

Publication number
SE9101807D0
SE9101807D0 SE9101807A SE9101807A SE9101807D0 SE 9101807 D0 SE9101807 D0 SE 9101807D0 SE 9101807 A SE9101807 A SE 9101807A SE 9101807 A SE9101807 A SE 9101807A SE 9101807 D0 SE9101807 D0 SE 9101807D0
Authority
SE
Sweden
Prior art keywords
cells
protoporphyrin
disclosed
light
protoporphyrinogen
Prior art date
Application number
SE9101807A
Other languages
English (en)
Other versions
SE505938C2 (sv
SE9101807L (sv
Inventor
B P Halling
Original Assignee
Fmc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Corp filed Critical Fmc Corp
Publication of SE9101807D0 publication Critical patent/SE9101807D0/sv
Publication of SE9101807L publication Critical patent/SE9101807L/sv
Publication of SE505938C2 publication Critical patent/SE505938C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SE9101807A 1988-12-12 1991-06-12 Protoporfyrinogen inhibitorer och användning därav i kompositioner för att detektera och behandla tumörer SE505938C2 (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US28515188A 1988-12-12 1988-12-12
US33500789A 1989-04-07 1989-04-07
US35133189A 1989-05-03 1989-05-03
PCT/US1989/005599 WO1990006748A2 (en) 1988-12-12 1989-12-08 Use of certain herbicides in cancer treatment and production of protoporphyrin ix

Publications (3)

Publication Number Publication Date
SE9101807D0 true SE9101807D0 (sv) 1991-06-12
SE9101807L SE9101807L (sv) 1991-06-12
SE505938C2 SE505938C2 (sv) 1997-10-27

Family

ID=27403508

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9101807A SE505938C2 (sv) 1988-12-12 1991-06-12 Protoporfyrinogen inhibitorer och användning därav i kompositioner för att detektera och behandla tumörer

Country Status (28)

Country Link
EP (1) EP0447491B1 (sv)
JP (1) JP2545000B2 (sv)
KR (1) KR930003116B1 (sv)
AR (1) AR243605A1 (sv)
AT (1) AT400520B (sv)
AU (1) AU633537B2 (sv)
BR (1) BR8907817A (sv)
CA (1) CA2004979A1 (sv)
CH (1) CH681779A5 (sv)
DE (2) DE3991484C2 (sv)
DK (1) DK110791A (sv)
EG (1) EG18822A (sv)
ES (1) ES2051675T3 (sv)
FI (1) FI912784A0 (sv)
GB (1) GB2247404B (sv)
GR (1) GR1000609B (sv)
HU (1) HUT58202A (sv)
IE (1) IE62621B1 (sv)
IL (1) IL92622A (sv)
LU (1) LU87949A1 (sv)
LV (1) LV10303B (sv)
MC (1) MC2171A1 (sv)
NO (1) NO912228D0 (sv)
NZ (1) NZ231658A (sv)
OA (1) OA09362A (sv)
PT (1) PT92546B (sv)
SE (1) SE505938C2 (sv)
WO (1) WO1990006748A2 (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298502A (en) * 1988-12-12 1994-03-29 Fmc Corporation Method and composition for photodynamic treatment and detection of tumors
US5132101A (en) * 1990-05-04 1992-07-21 Cytopharm, Inc. Acetylene-cumulene porphycene compounds for photodynamic therapy
US5244671A (en) * 1991-01-29 1993-09-14 Cytopharm, Inc. Derivatives of porphycene for photodynamic therapy of cancer
US5179120A (en) * 1991-06-28 1993-01-12 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
TW492975B (en) * 1993-07-26 2002-07-01 Novartis Ag Tryptase inhibitor
GB9318841D0 (en) * 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
US6023012A (en) * 1996-02-28 2000-02-08 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase
US5939602A (en) * 1995-06-06 1999-08-17 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutants thereof
US5767373A (en) 1994-06-16 1998-06-16 Novartis Finance Corporation Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
US6084155A (en) * 1995-06-06 2000-07-04 Novartis Ag Herbicide-tolerant protoporphyrinogen oxidase ("protox") genes
KR19990087356A (ko) * 1996-02-28 1999-12-27 더블류. 하링, 지. 보이롤 식물 프로토포르피리노겐 옥시다제 유전자로부터의 프로모터
JPH10330359A (ja) * 1997-03-31 1998-12-15 Nippon Bayeragrochem Kk フエニルアセチレン誘導体及び除草剤
DE102005017152B4 (de) * 2005-04-13 2007-02-08 Lindauer Dornier Gmbh Verfahren zum Trocknen von vorzugsweise plattenförmigen Produkten und Durchlauftrockner in Mehretagenbauweise
ES2417312T3 (es) 2009-06-19 2013-08-07 Basf Se Benzoxazinonas herbicidas
BR112012009987A2 (pt) * 2009-11-02 2015-09-29 Basf Se ''tetraidroftalimidas de fórmula ia ,processo para preparação de composições herbicidas ativas e método para controlar vegetações indesejadas''
US8669208B2 (en) 2010-10-01 2014-03-11 Basf Se Herbicidal benzoxazinones
CN103260412B (zh) 2010-12-15 2015-09-02 巴斯夫欧洲公司 除草组合物
CN102875569A (zh) * 2012-09-27 2013-01-16 南开大学 具有除草活性和抗肝癌活性的异噁唑并嘧啶酮(或三嗪酮)类化合物
WO2018108695A1 (en) * 2016-12-16 2018-06-21 Basf Se Herbicidal phenyltriazolinones

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393071A (en) * 1975-03-17 1983-07-12 Naoharu Fujii Method of treating gastric, mammary, lung and uterus tumors
US4404019A (en) * 1980-12-24 1983-09-13 Sumitomo Chemical Company, Limited 3-Chloro-1-phenyl-1,2,4-triazolin-5-ones and their use as herbicides
CH651029A5 (de) * 1980-12-25 1985-08-30 Nihon Nohyaku Co Ltd Triazolin-derivate, verfahren zu ihrer herstellung und sie enthaltende herbizide mittel.
JPS60190711A (ja) * 1984-03-09 1985-09-28 Tokyo Tanabe Co Ltd プロトポルフイリン類注射用製剤
US4755217A (en) * 1987-01-15 1988-07-05 Fmc Corporation Triazinedione herbicides
US4761174A (en) * 1987-04-14 1988-08-02 Fmc Corporation Triazolin-5-one herbicides

Also Published As

Publication number Publication date
JP2545000B2 (ja) 1996-10-16
AU633537B2 (en) 1993-02-04
IL92622A (en) 1996-05-14
LU87949A1 (fr) 1991-12-16
WO1990006748A2 (en) 1990-06-28
KR910700046A (ko) 1991-03-13
CA2004979A1 (en) 1990-06-12
FI912784A0 (fi) 1991-06-10
OA09362A (en) 1992-09-15
GB2247404B (en) 1993-03-03
IE893925L (en) 1990-06-12
AU4822290A (en) 1990-07-10
JPH04501420A (ja) 1992-03-12
EP0447491A1 (en) 1991-09-25
DK110791A (da) 1991-08-12
GR890100817A (en) 1991-03-15
PT92546A (pt) 1990-06-29
WO1990006748A3 (en) 1990-10-04
CH681779A5 (sv) 1993-05-28
SE505938C2 (sv) 1997-10-27
EG18822A (en) 1994-09-29
EP0447491B1 (en) 1993-08-11
BR8907817A (pt) 1991-10-22
ES2051675T1 (es) 1994-07-01
DE3991484T (sv) 1991-11-21
DK110791D0 (da) 1991-06-11
PT92546B (pt) 1995-09-12
LV10303A (lv) 1994-10-20
NO912228L (no) 1991-06-11
NZ231658A (en) 1992-05-26
KR930003116B1 (ko) 1993-04-19
HUT58202A (en) 1992-02-28
GB9110472D0 (en) 1991-11-27
IE62621B1 (en) 1995-02-22
SE9101807L (sv) 1991-06-12
GR1000609B (el) 1992-08-31
AT400520B (de) 1996-01-25
LV10303B (en) 1995-08-20
AR243605A1 (es) 1993-08-31
ATA903489A (de) 1995-06-15
ES2051675T3 (es) 1994-11-01
DE3991484C2 (de) 1995-02-23
GB2247404A (en) 1992-03-04
NO912228D0 (no) 1991-06-11
IL92622A0 (en) 1990-08-31
MC2171A1 (fr) 1992-05-22

Similar Documents

Publication Publication Date Title
SE9101807L (sv) Framstaellning och anvaendning av porfyriner
Carlile The photobiology of fungi
PL322015A1 (en) Derivatives of hydroxylamine useful as compounds enhancing production of accompanying molecular protein and ethod of obtaining them
SE7900493L (sv) Interferon och interforonhaltiga beredningar
ES2166788T3 (es) Procedimiento para producir una sustancia.
DE69032809T2 (de) Herstellung von Proteinen mittels homologer Rekombination
FI915478A0 (fi) Producering av enzymer i froen och anvaendning av erhaollna froen.
ES8101385A1 (es) Un procedimiento para la preparacion de un derivado de una enzima fibrinolitica
ATE58624T1 (de) Kultur von morchella.
FI850449L (fi) Foerfarande foer framstaellning av (-) -trans-4-(4-fluorfenyl)-3-(4-metoxifenoxi)-metylpiperidin eller farmaceutiskt godtagbara syraadditionssalter daerav.
MX5937E (es) Procedimiento para la produccion de una biomasa bacteriostatica a partir de cepas de beggiatoa
DE69624937T2 (de) Verfahren zur verminderung der strahlentherapie oder der radiomimetischen chemotherapie bei der transplantation von hematopoietischen, pluripotenten zellen
ATE117376T1 (de) Herstellung von melanin.
DE69723077D1 (de) Wachstumshemmung und abtoetung solider tumore unter verwendung eines prolaktin-modulators und eines photosensitizers
PT86552A (de) Gama-glutamyl-transpeptidase deren herstellung und deren verwendung
GB396206A (en) Improvements in the manufacture of yeast and other microorganisms
DE3786705D1 (de) Verwendung eines ornithin-decarboxylate-inhibitors zur herstellung eines praeparats fuer die behandlung, zusammen mit lak-zellen und interleukin-2, von tumoren.
UA12840A1 (uk) Спосіб одержаhhя правообертових похідhих оксиізоіhдоліhіла або їх фармацевтичhо прийhятhих солей
JPS5668388A (en) Production of cell body of spirulina algae
Halling et al. Method and composition for photodynamic treatment and detection of tumors
GEP19970991B (en) Method for Decay of Tumor Cells with Mammalia and Pharmacentical Composition for this Purpose
PT90039A (pt) Processo de preparacao de oxidos de 1,2,4-benzotriazina e de composicoes faemaceuticas que os contem
ATE69551T1 (de) Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren.
RU95101471A (ru) Способ получения препарата грамин
SE305843B (sv)

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 9101807-7

Format of ref document f/p: F